日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancer

整合热液活检、临床数据和质谱分析技术,用于结直肠癌的早期诊断和生物标志物发现

Hermoso-Durán, Sonia; Ortega-Alarcon, David; Johansen, Astrid Z; McKay, Mattew J; Johansen, Julia S; Vega, Sonia; Feltoft, Claus L; Dolin, Troels Gammeltoft; Lykke, Jakob; Fraunhoffer, Nicolas; Sanchez-Gracia, Oscar; Garrido, Pablo F; Lanas, Ángel; Molloy, Mark P; Velazquez-Campoy, Adrian; Abian, Olga

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma

SFRP1启动子高甲基化是转移性胰腺导管腺癌中一种等位基因频率依赖性的预后生物标志物

Stubbe, Benjamin; Stoico, Malene P; Terp, Simone K; Madsen, Poul H; Lundbye-Christensen, Søren; Hansen, Carsten P; Poulsen, Laurids Ø; Rasmussen, Louise S; Yilmaz, Mette N; Jensen, Lars H; Hansen, Torben F; Pfeiffer, Per; Larsen, Anders C; Krarup, Henrik B; Pedersen, Inge S; Hasselby, Jane P; Johansen, Astrid Z; Chen, Inna M; Johansen, Julia S; Thorlacius-Ussing, Ole; Henriksen, Stine D

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma.

sCD163 与 CA 19-9 联合检测可提高胰腺导管腺癌的预测准确性

Stuhr Liva K, Madsen Kasper, Johansen Astrid Z, Chen Inna M, Hansen Carsten P, Jensen Lars H, Hansen Torben F, Kløve-Mogensen Kirstine, Nielsen Kaspar R, Johansen Julia S

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma

血清中V型胶原C-前肽(PRO-C5)水平升高预示着胰腺导管腺癌患者的总生存期较短。

Nissen, Neel I; Johansen, Astrid Z; Chen, Inna M; Jensen, Christina; Madsen, Emilie A; Hansen, Carsten P; Thorlacius-Ussing, Jeppe; Karsdal, Morten; Johansen, Julia S; Diab, Hadi M H; Jørgensen, Lars N; Willumsen, Nicholas

Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer

循环蛋白在接受胰腺癌手术患者中的预后价值

Lindgaard, Sidsel C; Sztupinszki, Zsófia; Maag, Emil; Hansen, Carsten P; Chen, Inna M; Johansen, Astrid Z; Hasselby, Jane P; Bojesen, Stig E; Nielsen, Dorte; Johansen, Julia S

Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

通过测量血清中 III 型胶原蛋白前肽来量化纤维化活性,可用于不同实体瘤类型的预后评估。

Willumsen, Nicholas; Jensen, Christina; Green, George; Nissen, Neel I; Neely, Jaclyn; Nelson, David M; Pedersen, Rasmus S; Frederiksen, Peder; Chen, Inna M; Boisen, Mogens K; Johansen, Astrid Z; Madsen, Daniel H; Svane, Inge Marie; Lipton, Allan; Leitzel, Kim; Ali, Suhail M; Erler, Janine T; Hurkmans, Daan P; Mathijssen, Ron H J; Aerts, Joachim; Eslam, Mohammed; George, Jacob; Christiansen, Claus; Bissel, Mina J; Karsdal, Morten A

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

循环蛋白生物标志物在接受化疗的晚期胰腺导管腺癌患者预后中的应用

Lindgaard, Sidsel C; Maag, Emil; Sztupinszki, Zsófia; Chen, Inna M; Johansen, Astrid Z; Jensen, Benny V; Bojesen, Stig E; Nielsen, Dorte L; Szallasi, Zoltan; Johansen, Julia S

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab

血液纤维化生物标志物在接受化疗和贝伐单抗治疗的转移性结直肠癌患者中的预后价值

Nissen, Neel I; Kehlet, Stephanie; Boisen, Mogens K; Liljefors, Maria; Jensen, Christina; Johansen, Astrid Z; Johansen, Julia S; Erler, Janine T; Karsdal, Morten; Mortensen, Joachim H; Høye, Anette; Willumsen, Nicholas

Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.

血清IL6作为胆道癌的预后生物标志物,IL6R作为治疗靶点

Høgdall Dan, O'Rourke Colm J, Dehlendorff Christian, Larsen Ole F, Jensen Lars H, Johansen Astrid Z, Dang Hien, Factor Valentina M, Grunnet Mie, Mau-Sørensen Morten, Oliveira Douglas V N P, Linnemann Dorte, Boisen Mogens K, Wang Xin W, Johansen Julia S, Andersen Jesper B